Case Study | June 04, 2015 | Sponsored by RaySearch Laboratories

Advanced Planning for Accurate Proton Treatments at the Provision Center for Proton Therapy

RayStation Treatment Planning System provides required technologies to deliver high quality plans

Original treatment plan

Figure 1: Original treatment plan

Final adapted plan

Figure 2: Final adapted plan

Three field robust plan

Figure 3: Three field robust plan

DVH for final robust plan

Figure 4: DVH for final robust plan

Proton therapy is an exciting modality in radiation oncology. It is the target of both positive and negative perspectives - the positive related to the technology itself and the ability of proton beams to deposit energy mostly within the tumor being treated. The negative opinions generally result from the historically high cost to build and maintain a center and the lack of access for patients worldwide. The Provision Center for Proton Therapy has not only embraced proton therapy, but also the concept that it must be used in conjunction with other advanced technologies that will assure treatment accuracy. 

Because proton beams are so controllable, it is important to recognize that a treatment can accurately miss a cancerous tumor if the treatment is not planned and monitored carefully. In the case of conventional photon treatment courses, dosimetric errors are not as likely to occur, and corrections are relatively easy to make. With protons, minor variations in patient shape and density, along with positioning error, can result in very significant differences in delivering the planned dose.

To this end the center has very successfully implemented two key technologies with its treatment planning system - robust optimization and adaptive therapy. RayStation from RaySearch Laboratories allows staff to create very advanced plans quickly and efficiently.

Adaptive Planning

The first example demonstrates how important it can be to modify plans based on changes during treatment. A woman presented with a right breast cancer that was very large and invasive. It was expected that the patient would have a fast response so weekly QA CTs were performed during treatment. Deformable registration was used to determine if the existing plan had adequate coverage. Soon after the treatment commenced, the scans showed significant changes that warranted replanning. The center used the adaptive planning function in RayStation to quickly replan the case and get back to the prescribed dose. The adaptive planning function does not require that the user re-enter the beam parameters or the inverse planning objectives. In total four adapted plans were implemented over the course of treatment with only a day or so needed each time to complete the planning and quality assurance. The sum of the doses was easily displayed so that an overall analysis could be made on the efficacy of the delivery. Adaptive planning in a case like this is simply unavoidable - in the case of protons that are sensitive to density and anatomical changes in the body, it would be impossible to plan this in an efficient and/or safe manner without advanced technologies such as deformable registration and adaptive therapy.

Robust Optimization

Protons are very sensitive to changes in density and patient shape.
Therefore, variations in patient positioning can have dramatic effects on the dose distribution. The use of planning target volumes (PTVs) to account for these variations is not always sufficient to achieve a robust plan. To enable the creation of robust plans for cases, where conventional margins do not work, RayStation implements, instead, robust optimization, which explicitly takes these variations into account and aims for a plan that is as good as possible with respect to the worst case variation.

The patient in a second clinical case (Figures 3 and 4) had a clinical target volume (CTV) that was anterior on the sternum but also a CTV in the mediastinum behind the great vessels. A plan was designed to treat the anterior CTV with an AP beam and the posterior CTV with posterior obliques. However, the lung interface and the fact that the CTVs overlapped superior/inferior presented a challenge. Instead of treating single field uniform dose (SFUD) and irradiating more lung and heart tissue, robust optimization was utilized. This allowed the team to account for range uncertainty in a very heterogeneous area, and ensure that with setup error and range uncertainty there would be no unacceptable hot or cold spots. Uniform dose was achieved in a robust manner, even where the CTVs overlapped. Robust optimization further eliminated the need for beam specific PTVs and a complicated optimization process.

Proton therapy requires a very high level of focus and treatment planning technology. Intensity modulated proton therapy (IMPT) in RayStation allows for quick, efficient, robust and adaptive planning for effective proton treatments.

Case study supplied by RaySearch Laboratories.

Related Content

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...
Eclipse v16 has received CE mark and is 510(k) pending
News | Proton Therapy | April 06, 2020
April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technolo
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
IBA ProteusOne proton therapy system
News | Proton Therapy | January 29, 2020
January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down
Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Feature | Radiation Oncology | January 03, 2020 | Dave Fornell, Editor
January 3, 2020 — Here is the top 20 pieces of radiation oncology content on the Imaging Technology News (ITN) websit
Sponsored Content | Videos | Proton Therapy | December 16, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a peek at the history of machine learning/AI in
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
ProTom International received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radiance 330 proton therapy system
News | Proton Therapy | October 07, 2019
ProTom International received 510(k) clearance from the U.S.
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
News | Proton Therapy | September 20, 2019
Varian announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360...